In another study on transgenic mice predisposed to breast cancer, Epitalon extended lifespan, reduced tumor size and number, and decreased lung metastases
Yes, typical protocols suggest starting at 200 mcg daily and gradually increasing the dose by about 200 mcg every two weeks, as tolerated, up to a maximum of 600 mcg daily
For guidance on evaluating research peptide suppliers more broadly, see our article on How to Source High-Purity BPC-157: What Laboratories Should Evaluate and Choosing a Trusted Supplier for TB-500 Research Peptide
Injectable GHK-Cu has no published human clinical trials
Because robust human safety data are limited, it is difficult to give a definitive side-effect profile with meaningful incidence rates
Weekly dosage recommendations vary depending on individual factors such as health history, goals, and method of administration